trexate. When she came to me her vision was so impaired she did not drive any longer. I changed her diet to an alkaliz- ing one, put her on an allergy- eliminating rotation diet, used chelation therapy via supposi- tory, added in antioxidants and systemic enzymes, and abun- dant glycophospholipids. In the course of a year her vision steadily improved. She no lon- ger had attacks of optic neuri- tis. One day she announced to me she had driven to her own appointments. You can see that working with my patients is a blessed experience. I don’t have to be a rocket scientist. I sim- ply love my patients and teach them to understand inflamma- tion and repair of inflammation in the body.


Focus: Do you see evidence of the cell membrane restoration in laboratory blood analysis?


RE: Absolutely. Cell mem- brane damage leads to an in- crease in inflammatory mark- ers across the board—sed rate, C-reactive protein, homo- cysteine. After about a month of supplementing with glyco- phospholipids, we see a reduc- tion of inflammatory markers across the board. I should em- phasize, however, that I don’t simply supplement glycophos- pholipids. I take time to sit with each patient and explain all the changes that are necessary for well being, from good, alkaline water, to a low-carbohydrate less sugary diet, to avoiding genetically modified foods, to


6 Focus August 2012


heavy metals. My clinical labs monitor inflammatory mark- ers. I have patients that are nonagenarians and have chil- dren. I see the same reduction in cytokines, and without ex- ception. Again, without excep- tion my patients improve with the use of glycophospholip- ids, including my elderly with memory problems.


Focus: Is Lipid Replacement Therapy (LRT®) compatible with medication?


RE: Absolutely. I have pa- tients coming to me with as many as 10, 12, 15 medica- tions that they are on. In fact, many of my patients are able to come off of their polyphar- macy. This in part is due to the fact that glycophospholipids are supportive to membrane function and therefore the as- sistance of pharmaceuticals is no longer needed.


Focus: Do you see any im- provements in immune function?


RE: Yes. The largest immune dysfunction occurs in the can- cer patients that I see as part of my general population, espe- cially those who are in concur- rent chemotherapeutic treat- ment. They are, in fact, able to sustain their chemotherapies, and they don’t usually require transfusions or Neupogen shots to sustain their white blood cell counts. They also don’t experi- ence the kind of treatment-relat- ed fatigue that other cancer pa- tients do. I also see non-cancer


patients with abnormally low white blood cell counts. Twenty or thirty years ago I didn’t see these kind of low counts, but they are more common today, and these patients, too, see im- provement in total white blood cell counts with Lipid Replace- ment Therapy (LRT®).


Focus: Many patients un- dergoing chemotherapy ex- perience profound fatigue. As many as a third claim never to recover their previous levels of energy again. Is this treatment of use for these patients?


RE: I have patients who have gone through total bone mar- row transplants for their can- cer and they come back to me stating that their oncologist cannot believe their endurance, their health, their recovery rate and their ability to withstand the chemotherapeutic agents. After they are done with their treatments they do come back to their original energies.


Focus: Does this type of ther- apy help memory deficits and other aspects of aging?


RE: Yes, without a doubt. In my practice of mostly over- 50 patients, all the age-related diseases such as diabetes, heart disease, neurological dysfunc- tion, and cancer, show up. Yet my patients generally don’t suffer the way others do and I attribute this largely to teach- ing them about cell membrane repair, which allows them to enjoy many more golden years of excellent functioning.


Disclosure: Dr. Rita Ellithorpe, MD was reimbursed by NTI in 2006 for clinical trial expenses.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20